{
    "2500": {
        "explanation_text": "Albinism, unspecified.",
        "symptom_text": "The patient has a known history of albinism since birth.The patient presents with hypopigmented skin and hair, nystagmus, photophobia, and impaired visual acuity.Genetic testing confirmed the presence of albinism.Albinism, unspecified. Verbatim EHR quote justifying the code: 'The patient is diagnosed with Albinism, presenting with hypopigmented skin and hair, nystagmus, photophobia, and impaired visual acuity.'The patient's condition is consistent with a diagnosis of albinism. Management includes sun protection measures and regular ophthalmologic follow-up.Prescribed sunblock for skin protection and advised on the use of sunglasses for photophobia.The patient is stable and discharged with recommendations for long-term sun protection and ophthalmologic care.25FemaleCaucasian"
    },
    "2501": {
        "explanation_text": "Other disorders of amino-acid transport.",
        "symptom_text": "The patient has a history of episodic confusion, lethargy, and developmental delays.The patient presents with episodes of confusion, lethargy, and failure to thrive.Laboratory tests reveal elevated levels of specific amino acids in the blood and urine.Other disorders of amino-acid transport (ICD-10-CM code E7209) - The patient presents with episodic confusion, lethargy, and developmental delays. Laboratory tests show elevated levels of specific amino acids in the blood and urine.The patient's symptoms are consistent with a disorder of amino-acid transport, leading to the diagnosis of E7209.The patient was started on a specialized diet low in specific amino acids and was referred to a metabolic specialist for further management.The patient responded well to the treatment and was discharged with a follow-up plan in place.5 years oldMaleCaucasian"
    },
    "2502": {
        "explanation_text": "Homocystinuria.",
        "symptom_text": "The patient has a known history of Homocystinuria, a genetic disorder affecting methionine metabolism.The patient presents with symptoms of ectopia lentis, intellectual disability, and a history of thromboembolic events.Laboratory tests indicate elevated homocysteine levels and confirm the diagnosis of Homocystinuria.Homocystinuria (ICD-10-CM code E7211): 'Homocystinuria is an inherited disorder of the metabolism of the amino acid methionine characterized by ectopia lentis, intellectual disability, and a tendency for thromboembolic events.'The patient's physical examination is consistent with the findings of Homocystinuria, including the characteristic ectopia lentis. The patient's history of thromboembolic events further supports the diagnosis.The patient is being managed with a low-methionine diet, vitamin B6 supplementation, and anticoagulant therapy to prevent thromboembolic complications.The patient's condition is stable, and arrangements have been made for close follow-up to monitor the response to treatment and prevent complications.17FemaleCaucasian"
    },
    "2503": {
        "explanation_text": "Gaucher disease.",
        "symptom_text": "The patient has a history of splenomegaly noted during a routine check-up three months ago. There is no family history of similar conditions.The patient presents with fatigue, easy bruising, and frequent nosebleeds. Abdominal discomfort and bone pain are also reported.Laboratory tests reveal pancytopenia with low hemoglobin and platelet counts. Imaging shows hepatosplenomegaly.Gaucher disease, type 1, without neuronopathic involvement. The diagnosis is supported by the presence of hepatosplenomegaly, pancytopenia, and reduced glucocerebrosidase enzyme activity.The patient shows classical signs of Gaucher disease with hepatosplenomegaly and hematological abnormalities. Genetic testing is pending to confirm the specific mutation.Enzyme replacement therapy with imiglucerase has been initiated to address the underlying enzyme deficiency. Regular follow-ups and monitoring for disease progression are scheduled.The patient responded well to the enzyme replacement therapy during the hospital stay. Discharge instructions include adherence to the treatment plan and follow-up visits to monitor treatment response and disease progression.42FemaleCaucasian"
    },
    "2504": {
        "explanation_text": "Pure hypercholesterolemia, unspecified.",
        "symptom_text": "The patient has a history of high cholesterol levels during routine check-ups.The patient is asymptomatic and denies any symptoms related to lipid disorders.Recent lab results show elevated total cholesterol levels of 300 mg/dL with LDL cholesterol of 220 mg/dL and HDL cholesterol of 50 mg/dL.Pure hypercholesterolemia, unspecifiedPatient presents with no symptoms suggestive of other lipid disorders. No family history of familial hypercholesterolemia. Diagnosis of pure hypercholesterolemia based on elevated total cholesterol levels and lipid profile results.Prescribed a low-cholesterol diet and atorvastatin 20mg daily to manage cholesterol levels.The patient was educated on lifestyle modifications and medication adherence. Follow-up lipid panel scheduled in 3 months to monitor response to treatment.45MaleCaucasian"
    },
    "2505": {
        "explanation_text": "Pure hypercholesterolemia, unspecified.",
        "symptom_text": "The patient has a family history of hypercholesterolemia but no known familial genetic mutations related to cholesterol metabolism.The patient is asymptomatic and denies any chest pain, shortness of breath, or peripheral edema.Lipid panel results show elevated total cholesterol and LDL levels with normal triglycerides.Pure hypercholesterolemia, unspecified. Verbatim EHR quote justifying the code: 'Patient presents with elevated total cholesterol and LDL levels on lipid panel, consistent with a diagnosis of pure hypercholesterolemia.'Patient counseled on lifestyle modifications including dietary changes and exercise to help manage cholesterol levels.Prescribed atorvastatin 20mg daily to lower cholesterol levels.45FemaleCaucasian"
    },
    "2506": {
        "explanation_text": "Pure hyperglyceridemia.",
        "symptom_text": "The patient has a history of obesity and a sedentary lifestyle.The patient complains of recurrent episodes of abdominal pain and has a history of pancreatitis.Laboratory tests reveal elevated triglyceride levels of 250 mg/dL.Pure hyperglyceridemia (E781): The patient presents with elevated triglyceride levels without evidence of other lipid abnormalities.The patient is advised to follow a low-fat diet and increase physical activity to help manage triglyceride levels.The patient is prescribed fenofibrate to lower triglycerides and scheduled for a follow-up lipid profile in three months.N/A45MaleCaucasian"
    },
    "2507": {
        "explanation_text": "Mixed hyperlipidemia.",
        "symptom_text": "The patient has a history of mixed hyperlipidemia, with previous documentation of elevated cholesterol and triglyceride levels.The patient reports occasional chest pain and shortness of breath on exertion.Recent lipid panel results show elevated total cholesterol of 280 mg/dL and triglycerides of 220 mg/dL.Mixed hyperlipidemia, as evidenced by elevated levels of both cholesterol and triglycerides.Patient advised on lifestyle modifications including a low-fat diet and regular exercise. Follow-up lipid panel in 3 months recommended.Prescribed atorvastatin 20mg daily to manage cholesterol levels.The patient was discharged in stable condition with instructions to follow up with their primary care physician for further management of mixed hyperlipidemia.55MaleCaucasian"
    },
    "2508": {
        "explanation_text": "Other hyperlipidemia.",
        "symptom_text": "The patient has a history of obesity and a sedentary lifestyle.The patient is asymptomatic and denies any chest pain, shortness of breath, or abdominal discomfort.Lipid panel results show elevated total cholesterol and LDL levels.Other hyperlipidemia (ICD-10-CM code E7849) - The patient has elevated lipid levels without meeting the criteria for other specific hyperlipidemia disorders.The patient was counseled on lifestyle modifications, including dietary changes and increased physical activity.Prescribed atorvastatin 20mg daily for lipid management.The patient was discharged in stable condition with a follow-up appointment scheduled in 3 months.45FemaleCaucasian"
    },
    "2509": {
        "explanation_text": "Hyperuricemia without signs of inflammatory arthritis and tophaceous disease.",
        "symptom_text": "The patient has a history of occasional joint pain but denies any history of gout, arthritis, or tophaceous deposits.The patient presents with intermittent joint pain in the knees and ankles without any signs of inflammation or redness. No tophi are noted on examination.Serum uric acid levels are elevated at 8.5 mg/dL (normal range: 2.6-6.0 mg/dL). Renal function tests are within normal limits.Hyperuricemia without signs of inflammatory arthritis and tophaceous disease. Verbatim EHR quote justifying the code: 'The patient presents with elevated serum uric acid levels without clinical signs of inflammatory arthritis or tophaceous deposits.'The patient's joint pain is consistent with hyperuricemia, and the absence of tophi or joint inflammation suggests a non-inflammatory etiology.The patient is advised to follow a low-purine diet, increase fluid intake, and is prescribed allopurinol to lower uric acid levels.The patient responded well to treatment, with a decrease in joint pain. Discharged home with a follow-up appointment in two weeks.56MaleCaucasian"
    },
    "2510": {
        "explanation_text": "Gilbert syndrome.",
        "symptom_text": "The patient has a history of intermittent episodes of jaundice without any other significant medical conditions.The patient reports occasional yellowing of the skin and eyes, especially during times of stress or fasting. There are no complaints of abdominal pain, nausea, vomiting, or fatigue.Laboratory tests show unconjugated hyperbilirubinemia with normal liver function tests. Hemolysis markers are within normal limits.Gilbert syndrome is a benign condition characterized by intermittent jaundice due to unconjugated hyperbilirubinemia. The diagnosis is supported by the presence of indirect hyperbilirubinemia without evidence of hemolysis or liver pathology.The patient's physical examination is unremarkable except for the yellow discoloration of the skin and sclera. There are no signs of chronic liver disease or hemolytic anemia.No specific treatment is required for Gilbert syndrome. The patient is advised to avoid known triggers of jaundice and to maintain adequate hydration.The patient's symptoms of jaundice have improved during the hospital stay. The patient is discharged with instructions for follow-up with a primary care physician for routine monitoring of bilirubin levels.32MaleCaucasian"
    },
    "2511": {
        "explanation_text": "Other disorders of bilirubin metabolism.",
        "symptom_text": "The patient has a history of intermittent episodes of jaundice and elevated bilirubin levels.The patient presents with yellowing of the skin and sclera, along with generalized weakness.Laboratory tests show elevated levels of unconjugated bilirubin and normal liver function tests.Other disorders of bilirubin metabolism (ICD-10-CM code E806): The patient presents with intermittent jaundice, elevated unconjugated bilirubin levels, and normal liver function tests, consistent with a disorder of bilirubin metabolism.The patient reports a family history of similar episodes of jaundice. Physical examination reveals jaundice and mild hepatomegaly.The patient is advised to follow a low-fat diet and avoid fasting. Ursodeoxycholic acid is prescribed to help improve bile flow.The patient responded well to treatment and was discharged with instructions for follow-up liver function tests in two weeks.45FemaleCaucasian"
    },
    "2512": {
        "explanation_text": "Hereditary hemochromatosis.",
        "symptom_text": "The patient has a family history of hemochromatosis. No history of repeated red blood cell transfusions or other disorders of iron metabolism.The patient presents with fatigue, joint pain, and abdominal pain. No symptoms of hyperlipidemia, hyperuricemia, or other disorders of calcium or magnesium metabolism.Serum iron levels are elevated, transferrin saturation is increased, ferritin levels are high. Liver function tests show mild elevation of liver enzymes.Hereditary hemochromatosis - E83110: Hemochromatosis, hereditary, with iron overloadThe patient has classic symptoms and laboratory findings consistent with hereditary hemochromatosis. Genetic testing confirmed the presence of HFE gene mutations.Phlebotomy initiated to reduce iron levels. Dietary recommendations provided to limit iron intake.Patient responded well to phlebotomy treatments. Scheduled for regular follow-ups to monitor iron levels and adjust treatment as needed.45MaleCaucasian"
    },
    "2513": {
        "explanation_text": "Hemochromatosis due to repeated red blood cell transfusions.",
        "symptom_text": "The patient has a history of beta-thalassemia major and has been receiving regular red blood cell transfusions for the past 10 years to manage chronic anemia.The patient presents with joint pain, fatigue, and abdominal pain.Laboratory tests show elevated serum ferritin levels of 1200 ng/mL and genetic testing confirmed the presence of the C282Y mutation.Hemochromatosis due to repeated red blood cell transfusions. Verbatim EHR quote justifying the code: 'The patient is diagnosed with hemochromatosis secondary to repeated red blood cell transfusions leading to iron overload.'The patient reports worsening joint pain and fatigue over the last few months. Abdominal ultrasound shows evidence of liver iron overload.The patient is scheduled for therapeutic phlebotomy to reduce iron levels.The patient responded well to treatment and was discharged with a plan for regular phlebotomy sessions to manage iron overload.45MaleCaucasian"
    },
    "2514": {
        "explanation_text": "Hypomagnesemia.",
        "symptom_text": "The patient has a history of chronic alcoholism and malabsorption syndrome.The patient presents with muscle weakness, tremors, and cardiac arrhythmias.Serum magnesium level is significantly low at 1.2 mg/dL (normal range: 1.7-2.2 mg/dL).Hypomagnesemia (ICD-10-CM code E8342): The serum magnesium level is significantly low at 1.2 mg/dL, indicating hypomagnesemia.The patient's symptoms of muscle weakness, tremors, and cardiac arrhythmias are consistent with severe hypomagnesemia. The low serum magnesium level further supports this diagnosis.The patient was started on intravenous magnesium sulfate supplementation and oral magnesium oxide. Monitoring of magnesium levels and ECG was initiated.The patient's serum magnesium levels improved with treatment, and symptoms resolved. Discharged with a prescription for oral magnesium supplements and advised to follow up with a gastroenterologist for further evaluation of malabsorption syndrome.56MaleCaucasian"
    },
    "2515": {
        "explanation_text": "Hypocalcemia.",
        "symptom_text": "The patient has a history of chronic kidney disease stage 3 and has been taking calcium supplements irregularly.The patient presents with muscle cramps, paresthesia in the extremities, and Chvostek's sign.Laboratory tests show low serum calcium levels of 7.8 mg/dL (normal range: 8.5 - 10.5 mg/dL) and low ionized calcium levels of 3.9 mg/dL (normal range: 4.6 - 5.3 mg/dL).Hypocalcemia. Verbatim EHR quote justifying the code: 'Laboratory tests reveal low serum calcium levels of 7.8 mg/dL and low ionized calcium levels of 3.9 mg/dL.'The patient's symptoms and diagnostic tests are consistent with Hypocalcemia. Started the patient on oral calcium supplements and recommended dietary changes.Prescribed oral calcium carbonate supplements to be taken daily. Advised the patient to increase intake of dairy products and leafy greens.The patient's symptoms improved with treatment, and serum calcium levels increased to 9.2 mg/dL at discharge. Provided instructions to continue calcium supplements and follow up with the primary care physician.58MaleCaucasian"
    },
    "2516": {
        "explanation_text": "Hypercalcemia.",
        "symptom_text": "The patient has a history of chronic kidney disease stage 3 and takes calcium supplements for osteoporosis.The patient presented with fatigue, constipation, and frequent urination.Laboratory tests revealed elevated serum calcium levels of 11.2 mg/dL (normal range: 8.5-10.5 mg/dL).Hypercalcemia (ICD-10-CM code E8352): The patient's elevated serum calcium levels of 11.2 mg/dL confirm the diagnosis of hypercalcemia.The patient's symptoms and lab results are consistent with hypercalcemia. Further evaluation ruled out other causes of elevated calcium levels.The patient was advised to discontinue calcium supplements and increase fluid intake. A follow-up appointment was scheduled with an endocrinologist.The patient's symptoms improved with treatment, and serum calcium levels normalized. Discharge instructions included dietary modifications to prevent recurrence.65FemaleCaucasian"
    },
    "2517": {
        "explanation_text": "Other disorders of calcium metabolism.",
        "symptom_text": "The patient has a history of recurrent kidney stones and chronic renal insufficiency.The patient presents with muscle cramps, numbness, and tingling in the extremities.Lab results show elevated serum calcium levels and low urinary calcium excretion.Other disorders of calcium metabolismThe patient's symptoms and lab findings are consistent with a disorder of calcium metabolism. No evidence of hemochromatosis, iron metabolism disorder, phosphorus metabolism disorder, magnesium imbalance, or other mineral metabolism disorders.Treatment includes hydration, dietary adjustments to manage calcium levels, and referral to a nephrologist for further evaluation.The patient was discharged home with instructions to follow up with the nephrology clinic for ongoing management of the calcium disorder.58FemaleCaucasian"
    },
    "2518": {
        "explanation_text": "Other disorders of mineral metabolism.",
        "symptom_text": "The patient has a history of chronic kidney disease stage 3 and has been on long-term vitamin D supplementation for secondary hyperparathyroidism.The patient presents with generalized weakness, bone pain, and muscle cramps.Laboratory results show elevated parathyroid hormone levels and low serum phosphorus levels.Other disorders of mineral metabolism (E8389): The patient presents with generalized weakness, bone pain, and muscle cramps, along with elevated parathyroid hormone levels and low serum phosphorus levels.The patient's symptoms and lab findings are consistent with disturbances in mineral metabolism, specifically phosphorus imbalance, leading to the diagnosis of Other disorders of mineral metabolism.The patient was started on phosphorus supplements and advised dietary modifications to address the mineral metabolism disorder.The patient responded well to treatment and was discharged with a plan for follow-up monitoring of phosphorus levels.58FemaleCaucasian"
    },
    "2519": {
        "explanation_text": "Disorder of mineral metabolism, unspecified.",
        "symptom_text": "The patient has a history of recurrent kidney stones and a family history of osteoporosis.The patient complains of generalized weakness and bone pain.Laboratory tests reveal abnormal levels of calcium, phosphorus, and magnesium.Disorder of mineral metabolism, unspecified (ICD-10-CM code E839): Abnormal findings in the levels of calcium, phosphorus, and magnesium without specifying a particular mineral.The patient's symptoms and lab results are consistent with a generalized disorder of mineral metabolism, indicating a need for further evaluation and management.The patient was started on oral mineral supplements and advised dietary modifications.The patient's symptoms improved with treatment, and they were discharged with recommendations for follow-up monitoring of mineral levels.55FemaleCaucasian"
    },
    "2520": {
        "explanation_text": "Cystic fibrosis, unspecified.",
        "symptom_text": "The patient has a history of recurrent respiratory infections, failure to thrive, and pancreatic insufficiency.The patient presents with chronic cough, wheezing, and recurrent episodes of pneumonia. Additionally, there are signs of malabsorption and poor weight gain.Sweat chloride test results show elevated levels consistent with Cystic fibrosis. Genetic testing confirmed mutations in the CFTR gene.Cystic fibrosis, unspecified: The diagnosis of Cystic fibrosis is supported by the patient's history of recurrent respiratory infections, pancreatic insufficiency, elevated sweat chloride levels, and genetic confirmation of CFTR gene mutations.The patient's physical exam reveals digital clubbing and crackles upon auscultation. The patient is being started on pancreatic enzyme replacement therapy and chest physiotherapy.Treatment plan includes pancreatic enzyme replacement, chest physiotherapy, nutritional support, and close monitoring of respiratory status.The patient was discharged home with instructions for airway clearance techniques, dietary modifications, and follow-up with the pulmonology and gastroenterology clinics.9 years oldFemaleCaucasian"
    },
    "2521": {
        "explanation_text": "Other amyloidosis.",
        "symptom_text": "The patient has a history of chronic kidney disease stage 3 and hypertension.The patient presented with generalized edema, proteinuria, and fatigue.Serum and urine protein electrophoresis showed abnormal protein deposits consistent with amyloidosis. Renal biopsy confirmed the presence of amyloid deposits in the kidney tissue.Other amyloidosis (E8589): Amyloidosis not elsewhere classifiedThe patient's symptoms, along with the diagnostic test results, are indicative of Other amyloidosis. No evidence of hypercalcemia, hypocalcemia, or other mineral metabolism disorders was found.The patient was started on angiotensin-converting enzyme inhibitors for blood pressure control and referred to a nephrologist for further management of amyloidosis.The patient was discharged in stable condition with close follow-up recommended for monitoring kidney function and disease progression.67FemaleCaucasian"
    },
    "2522": {
        "explanation_text": "Amyloidosis, unspecified.",
        "symptom_text": "The patient has a history of intermittent unexplained weight loss over the past six months, with no other significant medical conditions reported.The patient presents with generalized edema, particularly noticeable in the lower extremities, along with persistent fatigue and shortness of breath on exertion.Serum protein electrophoresis revealed the presence of monoclonal immunoglobulin light chains. Abdominal fat pad biopsy demonstrated amyloid deposits.Amyloidosis, unspecifiedThe patient's symptoms, along with the diagnostic test results showing monoclonal immunoglobulin light chains and amyloid deposits, are consistent with a diagnosis of Amyloidosis, unspecified.The patient has been started on a treatment plan including diuretics for edema management and referral to hematology for further evaluation and management of the underlying condition.The patient's symptoms have improved with treatment, and arrangements have been made for outpatient follow-up with the hematology department for ongoing care and monitoring.58FemaleCaucasian"
    },
    "2523": {
        "explanation_text": "Dehydration.",
        "symptom_text": "The patient has a history of occasional episodes of vomiting and diarrhea.The patient presents with dry mouth, decreased urine output, dizziness upon standing, and fatigue.Laboratory tests show elevated blood urea nitrogen (BUN) and creatinine levels, indicating dehydration.DehydrationThe patient's symptoms and lab results are consistent with dehydration. Rehydration therapy has been initiated.The patient is receiving intravenous fluids and electrolyte replacement.The patient responded well to treatment and was discharged with instructions to maintain adequate hydration.45FemaleCaucasian"
    },
    "2524": {
        "explanation_text": "Hypovolemia.",
        "symptom_text": "The patient has a history of chronic kidney disease stage 3 and hypertension.The patient presents with weakness, dizziness, tachycardia, and decreased urine output.Laboratory results indicate low blood pressure, elevated blood urea nitrogen (BUN), and creatinine levels. Electrolyte panel shows hyponatremia and hypochloremia.Hypovolemia. The patient presents with symptoms of weakness, dizziness, tachycardia, and laboratory findings of low blood pressure, elevated BUN, creatinine, hyponatremia, and hypochloremia, indicative of hypovolemia.Patient appears lethargic and orthostatic. Blood pressure significantly drops upon standing. Electrolyte imbalance is consistent with hypovolemia. Plan to initiate fluid resuscitation.The patient was treated with intravenous fluids to restore blood volume and electrolyte balance. Close monitoring of vital signs and urine output was initiated.Patient responded well to fluid resuscitation, with symptoms of weakness and dizziness resolving. Stable blood pressure and improved urine output. Discharged with recommendations for follow-up with nephrology for further management of chronic kidney disease and hypertension.65FemaleCaucasian"
    },
    "2525": {
        "explanation_text": "Hyperosmolality and hypernatremia.",
        "symptom_text": "The patient has a history of diabetes insipidus and hypertension.The patient presents with extreme thirst, confusion, and seizures.Laboratory results show serum osmolality of 320 mOsm/kg and serum sodium levels of 155 mEq/L.Hyperosmolality and hypernatremiaThe patient's symptoms and diagnostic tests confirm the diagnosis of Hyperosmolality and hypernatremia. No other underlying conditions are evident.The patient was treated with intravenous fluids to correct the electrolyte imbalance and was closely monitored for neurological symptoms.The patient responded well to treatment and was discharged with instructions for fluid intake monitoring and follow-up with the endocrinologist.58MaleCaucasian"
    },
    "2526": {
        "explanation_text": "Hypo-osmolality and hyponatremia.",
        "symptom_text": "The patient has a history of heart failure and chronic kidney disease.The patient presents with confusion, weakness, and generalized edema.Lab results show low serum osmolality and decreased serum sodium levels.Hypo-osmolality and hyponatremia. Verbatim: 'Patient diagnosed with Hypo-osmolality and hyponatremia.'The patient's symptoms and lab results are consistent with a diagnosis of Hypo-osmolality and hyponatremia. No signs of hyperosmolality or hypernatremia are present.The patient was treated with fluid restriction and intravenous saline solution.The patient's condition improved with treatment, and they were discharged with instructions for follow-up sodium level monitoring.65MaleCaucasian"
    },
    "2527": {
        "explanation_text": "Mixed disorder of acid-base balance.",
        "symptom_text": "The patient has a history of chronic obstructive pulmonary disease (COPD) and hypertension.The patient presents with confusion, lethargy, and muscle weakness.Arterial blood gas analysis shows a pH of 7.35, pCO2 of 45 mmHg, and HCO3- of 22 mEq/L.Mixed disorder of acid-base balance (ICD-10-CM code E874): The arterial blood gas analysis reveals a pH within the normal range but with an elevated pCO2 and a slightly decreased HCO3-, indicating a mixed acid-base disorder with respiratory acidosis and metabolic alkalosis.The patient's confusion and lethargy are consistent with the acid-base imbalance observed in the blood gas analysis. There are no signs of respiratory distress or rapid breathing.The patient is being treated with oxygen therapy, intravenous fluids, and electrolyte monitoring.The patient responded well to treatment and was discharged with instructions for follow-up with the primary care physician.65MaleCaucasian"
    },
    "2528": {
        "explanation_text": "Hyperkalemia.",
        "symptom_text": "The patient has a history of chronic kidney disease stage 3 and hypertension.The patient presented with muscle weakness and irregular heartbeats.Potassium level in the blood test was 6.2 mEq/L (normal range: 3.5-5.0 mEq/L). ECG showed peaked T-waves.Hyperkalemia (E875): Elevated potassium level in the blood with associated symptoms of muscle weakness and cardiac arrhythmias.Patient's potassium levels are significantly elevated, leading to muscle weakness and ECG changes. Likely due to impaired kidney function.Treatment included intravenous calcium gluconate, insulin with dextrose, and sodium polystyrene sulfonate to lower potassium levels.The patient's condition improved with treatment, potassium levels normalized, and symptoms resolved. Discharged with instructions for dietary potassium restriction and follow-up with nephrology.67MaleCaucasian"
    },
    "2529": {
        "explanation_text": "Fluid overload, unspecified.",
        "symptom_text": "The patient has a history of hypertension and chronic kidney disease stage 3.The patient presents with generalized edema, shortness of breath, and weight gain.Laboratory tests show decreased urine output and elevated B-type natriuretic peptide (BNP) levels.Fluid overload, unspecified. The patient's presentation of generalized edema, shortness of breath, and weight gain, along with laboratory findings of decreased urine output and elevated BNP levels, support the diagnosis of fluid overload without specifying any other electrolyte imbalances or circulatory overload.The patient's edema is pitting and more prominent in the lower extremities. Auscultation reveals bilateral basal crackles. The patient is responsive to diuretic therapy.The patient was started on furosemide and advised on dietary sodium restriction. Close monitoring of fluid intake and output was initiated.The patient responded well to diuretic therapy with improved urine output and resolution of edema. Discharged home with follow-up scheduled in one week.65FemaleCaucasian"
    },
    "2530": {
        "explanation_text": "Other disorders of electrolyte and fluid balance, not elsewhere classified.",
        "symptom_text": "The patient has a history of hypertension and chronic kidney disease stage 3.The patient presents with mild confusion and muscle weakness.Lab tests show normal sodium, potassium, chloride, and bicarbonate levels. Creatinine clearance is slightly decreased.Other disorders of electrolyte and fluid balance, not elsewhere classified. Verbatim EHR quote justifying the code: 'The patient's lab results indicate normal electrolyte levels with a slightly decreased creatinine clearance, consistent with Other disorders of electrolyte and fluid balance.'The patient's confusion and muscle weakness are likely due to the electrolyte imbalance. No signs of acidosis, alkalosis, or specific metabolic disorders are present.The patient was treated with intravenous fluids and electrolyte replacement therapy.The patient's symptoms improved with treatment, and the electrolyte balance was restored. The patient was discharged in stable condition.68FemaleCaucasian"
    },
    "2531": {
        "explanation_text": "Alpha-1-antitrypsin deficiency.",
        "symptom_text": "The patient has a history of chronic lung disease and liver dysfunction.The patient presents with shortness of breath, wheezing, and jaundice.Laboratory tests show low levels of alpha-1-antitrypsin in the blood. Genetic testing confirms alpha-1-antitrypsin deficiency.Alpha-1-antitrypsin deficiency (ICD-10-CM code E8801): The patient has a history of chronic lung disease, liver dysfunction, presents with shortness of breath, wheezing, and jaundice. Laboratory tests show low levels of alpha-1-antitrypsin in the blood. Genetic testing confirms alpha-1-antitrypsin deficiency.The patient's presentation is consistent with alpha-1-antitrypsin deficiency. Further evaluation and management for this genetic disorder are warranted.The patient will be started on augmentation therapy to increase alpha-1-antitrypsin levels. Symptomatic treatment for lung and liver conditions will be initiated.The patient's condition improved with treatment. They are advised to follow up with a pulmonologist and hepatologist for ongoing management.45MaleCaucasian"
    },
    "2532": {
        "explanation_text": "Lipodystrophy, not elsewhere classified.",
        "symptom_text": "The patient has a history of Lipodystrophy, not elsewhere classified.The patient presents with generalized loss of body fat, leading to abnormal fat distribution, metabolic abnormalities, and insulin resistance.Laboratory tests show dyslipidemia, hypertriglyceridemia, and low levels of leptin.Lipodystrophy, not elsewhere classified (E881): Lipodystrophy, not elsewhere classifiedThe patient's physical examination reveals prominent muscularity due to the lack of subcutaneous fat. The patient reports difficulties in glycemic control despite adherence to diabetic management.Treatment includes dietary modifications, insulin sensitizers, and lipid-lowering agents.The patient was discharged in stable condition with a follow-up scheduled in three months to monitor treatment response.45FemaleCaucasian"
    },
    "2533": {
        "explanation_text": "Lipomatosis, not elsewhere classified.",
        "symptom_text": "The patient has a history of multiple lipomas, with the first lipoma appearing 5 years ago and gradually increasing in number over time.The patient reports the presence of multiple painless, soft, and mobile subcutaneous nodules across various body areas.Ultrasound imaging confirmed the presence of multiple lipomas in the subcutaneous tissue.Lipomatosis, not elsewhere classified. Lipomatosis is a condition characterized by the presence of multiple lipomas, which are benign tumors made of adipose tissue.Physical examination revealed multiple lipomas consistent with lipomatosis. No signs of lipodystrophy or metabolic abnormalities were noted.The patient was reassured about the benign nature of lipomas. Surgical removal of symptomatic or cosmetically concerning lipomas was discussed.The patient was discharged in stable condition with recommendations for regular follow-up to monitor the growth of lipomas and address any new symptoms.45FemaleCaucasian"
    },
    "2534": {
        "explanation_text": "Tumor lysis syndrome.",
        "symptom_text": "The patient has a known history of B-cell acute lymphoblastic leukemia.The patient presented with weakness, fatigue, nausea, and oliguria.Laboratory findings revealed hyperuricemia, hyperkalemia, hyperphosphatemia, and hypocalcemia.Tumor lysis syndrome (ICD-10-CM code E883) - \"Tumor lysis syndrome is a group of metabolic complications that can occur after the initiation of cancer treatment. It is characterized by the rapid release of intracellular components into the bloodstream, leading to electrolyte imbalances such as hyperuricemia, hyperkalemia, hyperphosphatemia, and hypocalcemia.\"The patient was started on aggressive intravenous hydration, allopurinol, and initiated on rasburicase for the management of tumor lysis syndrome.Treatment included hydration to maintain urine output, correction of electrolyte imbalances, and close monitoring of renal function.The patient responded well to treatment, with resolution of electrolyte imbalances and improvement in symptoms. Discharged home with close follow-up.45MaleCaucasian"
    },
    "2535": {
        "explanation_text": "MELAS syndrome.",
        "symptom_text": "The patient has a history of recurrent stroke-like episodes, muscle weakness, and exercise intolerance.The patient presents with severe headaches, vision and hearing problems, muscle pain, and cognitive impairment.Lab tests show elevated lactic acid levels, and muscle biopsy reveals ragged red fibers.Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome.The patient's symptoms, along with the diagnostic findings of elevated lactic acid and ragged red fibers, are consistent with MELAS syndrome.The patient is started on a regimen of coenzyme Q10 and other mitochondrial support therapies.The patient is discharged with a follow-up plan for genetic counseling and ongoing management of MELAS syndrome.32FemaleCaucasian"
    },
    "2536": {
        "explanation_text": "Other specified metabolic disorders.",
        "symptom_text": "The patient has a history of obesity, insulin resistance, and dyslipidemia.The patient presents with fatigue, increased thirst, and unintentional weight loss.Laboratory tests show elevated fasting blood glucose levels, dyslipidemia, and insulin resistance.Other specified metabolic disorders (ICD-10-CM code E8889): 'This code is used for metabolic disorders that do not have a specific code elsewhere in the ICD-10-CM system.'The patient's symptoms and diagnostic results are consistent with a metabolic disorder, and further evaluation is needed to determine the exact underlying cause.The patient is advised to follow a balanced diet, increase physical activity, and monitor blood glucose levels regularly.The patient was discharged in stable condition with recommendations for lifestyle modifications and close follow-up with a primary care provider.45FemaleCaucasian"
    },
    "2537": {
        "explanation_text": "Postprocedural hypothyroidism.",
        "symptom_text": "The patient has a history of thyroidectomy due to thyroid cancer.The patient presents with fatigue, weight gain, cold intolerance, and dry skin.Thyroid function tests show elevated TSH levels and low free T4 levels.Postprocedural hypothyroidismPatient's symptoms and lab results are consistent with a diagnosis of postprocedural hypothyroidism. Initiate levothyroxine therapy.Prescribed levothyroxine 50mcg daily.55FemaleCaucasian"
    },
    "2538": {
        "explanation_text": "Postprocedural hypoinsulinemia.",
        "symptom_text": "The patient is a 55-year-old male with a history of type 2 diabetes mellitus well controlled with metformin. He underwent a laparoscopic cholecystectomy three days ago.The patient presents with sweating, palpitations, and confusion post-surgery. Blood glucose levels are persistently low despite dextrose infusion.Blood tests show low serum insulin levels and elevated C-peptide levels. HbA1c is within the target range for his diabetes.Postprocedural hypoinsulinemia: Postprocedural hypoinsulinemia following a procedureThe patient's symptoms of sweating, palpitations, and confusion along with persistently low blood glucose levels despite dextrose support are indicative of postprocedural hypoinsulinemia. Diagnostic tests reveal low serum insulin levels and elevated C-peptide levels, confirming the diagnosis.The patient was started on intravenous insulin therapy to maintain euglycemia. Frequent monitoring of blood glucose levels and titration of insulin infusion were performed to ensure adequate control.The patient's blood glucose levels stabilized with intravenous insulin therapy. He was discharged with instructions for close follow-up with his endocrinologist to adjust his diabetes management in light of the postprocedural hypoinsulinemia.55MaleCaucasian"
    },
    "2539": {
        "explanation_text": "Postprocedural hypopituitarism.",
        "symptom_text": "The patient underwent pituitary surgery for the resection of a pituitary adenoma.The patient complains of fatigue, weight gain, cold intolerance, and decreased libido.Hormonal assay showed decreased levels of multiple pituitary hormones (e.g., ACTH, TSH, LH, FSH, GH). MRI revealed postoperative changes in the pituitary gland.Postprocedural hypopituitarism. Verbatim EHR quote justifying the code: 'The patient presents with decreased levels of multiple pituitary hormones post pituitary surgery, consistent with a diagnosis of Postprocedural hypopituitarism.'The endocrinologist noted the need for hormone replacement therapy to manage the deficiency of pituitary hormones.The patient was started on levothyroxine, hydrocortisone, and testosterone replacement therapy.The patient was discharged with instructions for hormone replacement therapy and scheduled follow-up visits with the endocrinologist.45FemaleCaucasian"
    },
    "2540": {
        "explanation_text": "Unspecified dementia, unspecified severity, without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety.",
        "symptom_text": "The patient has a history of hypertension and hyperlipidemia but no known history of endocrine or metabolic disorders.The patient presents with progressive memory loss, difficulty with language, and impairment of executive function. There are no symptoms of behavioral disturbance, psychotic disturbance, mood disturbance, or anxiety.MRI brain imaging shows generalized cortical atrophy consistent with dementia. Blood tests reveal no abnormalities in thyroid function, insulin levels, parathyroid function, pituitary function, or adrenal function.Unspecified dementia, unspecified severity, without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety. Verbatim EHR quote justifying the code: 'The patient presents with progressive memory loss, difficulty with language, and impairment of executive function. No symptoms of behavioral disturbance, psychotic disturbance, mood disturbance, or anxiety are noted.'The patient's family confirms a gradual decline in cognitive abilities over the past year. The patient is oriented to person but struggles with time and place. No signs of hallucinations, delusions, depression, or anxiety are observed.The patient is started on a cholinesterase inhibitor for the management of dementia. Caregiver education and support are initiated.The patient is discharged home with close follow-up with neurology for further management of dementia.78FemaleCaucasian"
    },
    "2541": {
        "explanation_text": "Amnestic disorder due to known physiological condition.",
        "symptom_text": "The patient has a history of hypertension and type 2 diabetes, both well-controlled with medications. No history of head trauma, substance abuse, or psychiatric disorders.The patient presents with progressive memory loss, particularly affecting recent events. No signs of behavioral disturbances, psychotic features, mood disturbances, or anxiety.MRI brain shows no structural abnormalities. Blood tests reveal normal thyroid function, vitamin B12 levels, and liver function tests.Amnestic disorder due to known physiological condition. The patient's memory impairment is the predominant deficit, without prominent behavioral, psychotic, or mood disturbances. The amnesia is attributed to a known physiological condition.The patient's family confirms a gradual onset of memory problems over the last 6 months. The patient is oriented to person and place but frequently forgets recent conversations and events. No evidence of hallucinations, delusions, or mood swings.Initiated cognitive rehabilitation therapy and recommended regular follow-ups. Prescribed vitamin E supplements for cognitive support.The patient responded well to therapy during hospitalization. Discharged with instructions for cognitive exercises and a follow-up appointment in 2 weeks.68MaleCaucasian"
    },
    "2542": {
        "explanation_text": "Postconcussional syndrome.",
        "symptom_text": "The patient is a 45-year-old male who sustained a head injury in a car accident a month ago.The patient presents with persistent headaches, difficulty concentrating, memory problems, irritability, and insomnia.Neuroimaging shows evidence of mild traumatic brain injury with no other significant findings.Postconcussional syndrome, as per the verbatim_EHR_quote_justifying_the_code.The patient's symptoms are consistent with postconcussional syndrome following the head injury. No signs of progressive cognitive decline or alcohol-related issues are noted.Patient advised on cognitive rest, stress management techniques, and scheduled for cognitive behavioral therapy sessions. Acetaminophen prescribed for headaches.The patient was discharged with instructions for gradual return to normal activities and follow-up appointments with the neurologist.45MaleCaucasian"
    },
    "2543": {
        "explanation_text": "Unspecified mental disorder due to known physiological condition.",
        "symptom_text": "The patient has a history of hypertension and type 2 diabetes managed with medications.The patient presents with progressive memory loss, confusion, and difficulty in concentrating. There are no reports of hallucinations, delusions, mood swings, or excessive worry.MRI shows mild atrophy in the temporal lobe consistent with the patient's age. Blood tests reveal normal thyroid function and vitamin B12 levels.Unspecified mental disorder due to known physiological condition (ICD-10-CM code F09): The patient presents with cognitive impairment without specific behavioral disturbances, psychotic features, mood disturbances, or anxiety.The patient's cognitive decline is attributed to the mild atrophy in the temporal lobe observed on MRI, indicating a physiological basis for the mental disorder.Started the patient on a cholinesterase inhibitor to help manage cognitive symptoms. Scheduled follow-up visits to monitor progress.The patient responded well to treatment with stabilization of cognitive symptoms. Discharged with instructions for medication adherence and follow-up appointments.68FemaleCaucasian"
    },
    "2544": {
        "explanation_text": "Alcohol abuse, uncomplicated.",
        "symptom_text": "The patient has a history of chronic alcohol abuse without any previous complications or comorbidities.The patient denies any current symptoms related to alcohol intoxication, withdrawal, mood disturbances, or cognitive impairments.Liver function tests show mild elevation of transaminases consistent with alcohol abuse but no evidence of liver cirrhosis or severe hepatic dysfunction.Alcohol abuse, uncomplicated. Verbatim EHR quote justifying the code: 'The patient presents with a history of chronic alcohol abuse without current signs of intoxication, withdrawal, or other alcohol-related complications.'Patient appears well-oriented, denies current alcohol use, and expresses motivation to engage in alcohol cessation programs.Initiated referral to addiction counseling services and recommended outpatient follow-up for support and monitoring.The patient is stable for discharge with arrangements made for continued support and follow-up care post-discharge.45MaleCaucasian"
    },
    "2545": {
        "explanation_text": "Alcohol abuse with intoxication, uncomplicated.",
        "symptom_text": "The patient has a history of chronic alcohol abuse without any previous complications or hospitalizations related to alcohol use.The patient presents with slurred speech, unsteady gait, and disinhibited behavior.Blood alcohol concentration of 0.18% confirming acute intoxication.Alcohol abuse with intoxication, uncomplicated. Verbatim ICD-10-CM's verbatim_EHR_quote_justifying_the_code: 'Patient presents with acute intoxication symptoms including slurred speech, unsteady gait, and positive blood alcohol concentration.'The patient's symptoms are consistent with acute alcohol intoxication without signs of delirium or mood disorders. No evidence of alcohol dependence or withdrawal symptoms.The patient was closely monitored, provided with intravenous fluids, and observed until the alcohol effects resolved.The patient responded well to treatment, and upon resolution of symptoms, was discharged with recommendations for alcohol cessation programs and follow-up with a substance abuse counselor.42MaleCaucasian"
    },
    "2546": {
        "explanation_text": "Alcohol abuse with intoxication delirium.",
        "symptom_text": "The patient has a history of chronic alcohol abuse.The patient presents with confusion, disorientation, hallucinations, and altered consciousness.Blood alcohol concentration of 0.25%, positive CAGE questionnaire for alcohol dependence.Alcohol abuse with intoxication delirium (ICD-10-CM code: F10121) - The patient presents with acute delirium, disorientation, and hallucinations in the setting of alcohol intoxication, meeting the criteria for F10121.The patient's symptoms are consistent with alcohol-induced delirium. No evidence of mood disorder, anxiety disorder, or other mental disorders due to physiological conditions.The patient was admitted for monitoring and received supportive care, intravenous fluids, and thiamine supplementation.The patient's delirium resolved with treatment, and they were discharged with recommendations for alcohol cessation programs and follow-up with addiction counseling.45MaleCaucasian"
    },
    "2547": {
        "explanation_text": "Alcohol abuse with alcohol-induced mood disorder.",
        "symptom_text": "The patient has a history of chronic alcohol abuse and has experienced recurrent mood disturbances associated with alcohol use.The patient presents with irritability, anxiety, and depressive symptoms triggered by alcohol consumption.Laboratory tests show elevated liver enzymes consistent with alcohol-induced liver damage.Alcohol abuse with alcohol-induced mood disorder (F10.14) - The patient's mood disturbances are directly linked to alcohol use. Verbatim EHR quote justifying the code: 'The patient presents with mood disturbances that are consistently associated with alcohol intake.'The physician notes the patient's history of failed attempts to cut down on alcohol consumption and the clear exacerbation of mood symptoms following alcohol intake.The patient has been started on a detoxification regimen and referred for psychotherapy to address the underlying alcohol abuse and mood disorder.The patient responded well to treatment, and arrangements have been made for outpatient follow-up to support ongoing sobriety and mental health management.42MaleCaucasian"
    },
    "2548": {
        "explanation_text": "Alcohol abuse with other alcohol-induced disorder.",
        "symptom_text": "The patient has a history of chronic alcohol abuse and has previously experienced alcohol-induced mood disorders.The patient presents with aggressive behavior, impaired judgment, and mood swings.Blood alcohol level is elevated at 0.15%. Liver function tests show mild elevation of transaminases consistent with alcohol-induced liver injury.Alcohol abuse with other alcohol-induced disorder (F10.188) - The patient presents with aggressive behavior, impaired judgment, and mood swings, consistent with alcohol-induced behavioral changes.The patient reports a long-standing history of heavy alcohol consumption. Physical examination reveals jaundice and signs of malnutrition. The diagnostic criteria for alcohol abuse with other alcohol-induced disorder are met based on the patient's history, symptoms, and lab test results.The patient is started on a detoxification protocol with close monitoring for alcohol withdrawal symptoms. Psychiatric evaluation is planned to address the underlying mood disorder induced by alcohol abuse.The patient responded well to the detoxification protocol and psychiatric interventions. Discharged with a referral to an outpatient alcohol rehabilitation program.45MaleCaucasian"
    },
    "2549": {
        "explanation_text": "Alcohol dependence with intoxication delirium.",
        "symptom_text": "The patient has a history of chronic alcohol use disorder and has previously undergone outpatient treatment for alcohol dependence.The patient presents with severe confusion, hallucinations, tremors, and disorientation. There is evidence of autonomic hyperactivity.Blood alcohol concentration is elevated at 0.20%. The liver function tests show mild elevation of transaminases.Alcohol dependence with intoxication delirium. The patient exhibits severe confusion, hallucinations, and autonomic hyperactivity in the setting of acute alcohol intoxication.The patient is disoriented to time and place, with fluctuating levels of consciousness. There are no focal neurological deficits noted.The patient was managed with benzodiazepines for alcohol withdrawal symptoms and close monitoring for delirium. Thiamine and folic acid supplementation were initiated.The patient's symptoms of delirium improved with treatment, and he was discharged with a referral to an addiction specialist for further management of alcohol dependence.42MaleCaucasian"
    },
    "2550": {
        "explanation_text": "Alcohol dependence with withdrawal delirium.",
        "symptom_text": "The patient has a history of chronic alcohol abuse and dependence.The patient presents with severe confusion, hallucinations, tremors, and autonomic hyperactivity.Laboratory tests show elevated liver enzymes and a positive blood alcohol level. EEG shows diffuse slowing consistent with delirium.Alcohol dependence with withdrawal delirium (F10231): The patient has a severe alcohol use disorder with withdrawal delirium, characterized by severe confusion, hallucinations, autonomic hyperactivity, and tremors. These symptoms are distinct from intoxication delirium or other alcohol-induced disorders.The patient is disoriented to time and place, has visual and auditory hallucinations, and exhibits signs of autonomic hyperactivity. The clinical presentation is consistent with alcohol withdrawal delirium.The patient was admitted for medical detoxification and received benzodiazepines for alcohol withdrawal management. Thiamine and folic acid supplementation were initiated to prevent Wernicke's encephalopathy.The patient responded well to treatment, with resolution of withdrawal symptoms. Discharged with a referral to outpatient addiction services for further management of alcohol use disorder.45MaleCaucasian"
    },
    "2551": {
        "explanation_text": "Alcohol dependence with alcohol-induced psychotic disorder with hallucinations.",
        "symptom_text": "The patient has a history of chronic alcohol dependence and has experienced recurrent episodes of alcohol-induced psychotic disorder with hallucinations.The patient presents with auditory and visual hallucinations, paranoid delusions, and disorganized behavior.Laboratory tests show elevated liver enzymes consistent with chronic alcohol use.Alcohol dependence with alcohol-induced psychotic disorder with hallucinations. Verbatim EHR quote justifying the code: 'Patient diagnosed with Alcohol dependence with alcohol-induced psychotic disorder with hallucinations.'The patient is experiencing severe alcohol withdrawal symptoms along with psychotic features. Started on benzodiazepines for alcohol withdrawal and antipsychotic medication for psychotic symptoms.The patient is being treated with a combination of benzodiazepines for alcohol withdrawal management and antipsychotic medication for alcohol-induced psychotic symptoms.The patient's condition improved with treatment, and arrangements have been made for outpatient follow-up for continued management of alcohol dependence and psychotic symptoms.42MaleCaucasian"
    },
    "2552": {
        "explanation_text": "Alcohol dependence with alcohol-induced persisting dementia.",
        "symptom_text": "The patient has a history of chronic alcohol abuse and has been previously diagnosed with alcohol dependence. There is a documented decline in cognitive function and memory loss over the past few years.The patient presents with memory deficits, impaired judgment, and cognitive decline. There are noticeable language difficulties and executive function impairment. The patient also experiences disorientation and confusion.Neuropsychological testing shows deficits in multiple cognitive domains, including memory, language, and executive function. MRI findings reveal cortical atrophy and white matter changes consistent with alcohol-induced persisting dementia.Alcohol dependence with alcohol-induced persisting dementia (F1027)The patient's symptoms of memory loss, cognitive decline, language difficulties, and executive function impairment are consistent with a diagnosis of alcohol-induced persisting dementia. The neuropsychological testing and MRI findings further support this diagnosis.The patient has been started on acetylcholinesterase inhibitors to help manage cognitive symptoms. Referral to a substance abuse counselor for alcohol dependence treatment has been made. Close monitoring of the patient's cognitive function and alcohol intake is recommended.The patient is stable and will follow up with neurology for further management of alcohol-induced persisting dementia and with addiction psychiatry for ongoing treatment of alcohol dependence.58MaleCaucasian"
    },
    "2553": {
        "explanation_text": "Alcohol use, unspecified with intoxication, unspecified.",
        "symptom_text": "The patient has a history of occasional alcohol use but no prior diagnosis of alcohol-related disorders.The patient presents with slurred speech, unsteady gait, and disinhibited behavior.Blood alcohol concentration of 180 mg/dL confirms acute intoxication.Alcohol use, unspecified with intoxication, unspecified. The patient presents with acute alcohol intoxication manifested by slurred speech, unsteady gait, and a blood alcohol concentration of 180 mg/dL.The patient denies any history of alcohol dependence, withdrawal symptoms, mood disorders, psychotic symptoms, or cognitive impairment. The focus is on managing acute intoxication.The patient was monitored closely, provided with intravenous fluids, and observed until alcohol levels decreased. Education on responsible alcohol use was also given.The patient's symptoms improved with supportive care, and upon normalization of blood alcohol levels, the patient was discharged in stable condition with advice to avoid excessive alcohol consumption.37MaleCaucasian"
    },
    "2554": {
        "explanation_text": "Alcohol use, unspecified with alcohol-induced mood disorder.",
        "symptom_text": "The patient has a history of chronic alcohol use and has experienced mood disturbances in the past.The patient presents with symptoms of depressed mood, irritability, and occasional outbursts of anger.Laboratory tests show elevated liver enzymes consistent with alcohol-induced liver damage.Alcohol use, unspecified with alcohol-induced mood disorder. The patient's mood disturbances are directly attributed to the chronic alcohol use.The patient denies any significant withdrawal symptoms or psychotic features. There are no indications of persisting amnestic or dementia symptoms. The focus remains on addressing the mood disorder induced by alcohol use.The patient is started on a medication regimen for mood stabilization and is referred to therapy for alcohol use disorder.The patient responded well to treatment and is advised to continue therapy for alcohol use disorder on an outpatient basis.42MaleCaucasian"
    },
    "2555": {
        "explanation_text": "Opioid abuse with intoxication, unspecified.",
        "symptom_text": "The patient has a history of chronic pain following a car accident two years ago, leading to the initial prescription of opioids for pain management.The patient presents with pinpoint pupils, drowsiness, slurred speech, and respiratory depression.Urine drug screen is positive for opioids confirming recent opioid use.Opioid abuse with intoxication, unspecified.The patient is disoriented and demonstrates poor coordination. No signs of alcohol use or withdrawal symptoms are noted.The patient was administered naloxone for opioid overdose reversal and is scheduled for a substance abuse counseling session.The patient's condition improved post naloxone administration, and arrangements have been made for follow-up care with an addiction specialist.42MaleCaucasian"
    },
    "2556": {
        "explanation_text": "Opioid dependence, in remission.",
        "symptom_text": "The patient has a history of chronic opioid use for pain management.The patient denies any current opioid use, withdrawal symptoms, or cravings. No symptoms of intoxication or mood disorders are reported.Urine drug screen is negative for opioids.Opioid dependence, in remission. The patient is in a controlled state regarding opioid use, with no current symptoms or cravings. The patient is engaged in a treatment plan focused on maintaining abstinence and preventing relapse.Patient shows good insight into their past opioid use and is actively participating in therapy sessions to address underlying triggers for substance use.Continuation of therapy sessions focusing on relapse prevention strategies. Referral to a support group for individuals with a history of substance use disorders.Patient discharged in stable condition with a follow-up appointment scheduled in two weeks to monitor progress and adjust the treatment plan if needed.42MaleCaucasian"
    },
    "2557": {
        "explanation_text": "Opioid dependence with intoxication, unspecified.",
        "symptom_text": "The patient has a history of chronic opioid use for pain management.The patient presents with drowsiness, slurred speech, and pinpoint pupils.Urine toxicology screening is positive for opioids.Opioid dependence with intoxication, unspecified. Verbatim ICD-10-CM's verbatim_EHR_quote_justifying_the_code: 'Opioid dependence with intoxication, unspecified.'Patient appears sedated but responsive. No signs of alcohol withdrawal or mood disturbances.Administered naloxone for opioid intoxication. Referral to addiction medicine for further management.Patient responded well to naloxone and was advised on the risks of continued opioid use.42MaleCaucasian"
    },
    "2558": {
        "explanation_text": "Opioid dependence with withdrawal.",
        "symptom_text": "The patient has a history of chronic back pain following a car accident five years ago, leading to the initial prescription of opioids for pain management.The patient presents with dilated pupils, diaphoresis, piloerection, severe muscle aches, abdominal cramping, and nausea.Urine toxicology screen positive for opioids and negative for other substances.Opioid dependence with withdrawalThe patient reports a strong craving for opioids, unsuccessful attempts to cut down opioid use, and significant distress due to withdrawal symptoms.Initiated buprenorphine-naloxone for opioid replacement therapy, provided counseling for substance use disorder, and referred to a rehabilitation program.The patient responded well to treatment, with improved symptoms and a plan in place for continued therapy post-discharge.38MaleCaucasian"
    },
    "2559": {
        "explanation_text": "Opioid dependence with other opioid-induced disorder.",
        "symptom_text": "The patient has a history of chronic opioid use for pain management following a motor vehicle accident five years ago. There are no documented instances of alcohol or cannabis abuse or dependence.The patient presents with tolerance to opioids, withdrawal symptoms upon cessation, and opioid-induced constipation. There are no symptoms of alcohol or cannabis use, abuse, or dependence.Urine toxicology screen is positive for opioids and negative for other substances. Liver function tests are within normal limits.Opioid dependence with other opioid-induced disorderThe patient acknowledges a strong craving for opioids and has unsuccessfully attempted to cut down or control opioid use. The patient also reports experiencing opioid-induced respiratory depression and sedation.The patient is started on a tapering schedule of buprenorphine-naloxone for opioid replacement therapy. Referral to a substance abuse counselor is made for additional support.The patient responded well to the buprenorphine-naloxone regimen and is advised to continue follow-up with the addiction medicine specialist for ongoing management.42MaleCaucasian"
    },
    "2560": {
        "explanation_text": "Opioid use, unspecified, uncomplicated.",
        "symptom_text": "The patient has a history of chronic pain due to a previous back injury sustained in a car accident five years ago. No history of alcohol or substance abuse.The patient reports persistent mild to moderate back pain and occasional headaches. Denies any symptoms of withdrawal or intoxication.Urine drug screen positive for opioids. Otherwise, all other lab results within normal limits.Opioid use, unspecified, uncomplicated. Verbatim EHR quote justifying the code: 'Patient's urine drug screen was positive for opioids, consistent with the history of chronic pain and absence of withdrawal symptoms.'Patient appears well-nourished and in no acute distress. Alert and oriented. Cooperative during the examination.Initiated a pain management plan with physical therapy and scheduled follow-up appointments. Prescribed acetaminophen for pain relief.Patient discharged in stable condition with a pain management plan in place. Advised on the safe use of opioids and potential side effects to watch for.42FemaleCaucasian"
    },
    "2561": {
        "explanation_text": "Opioid use, unspecified with unspecified opioid-induced disorder.",
        "symptom_text": "The patient has a history of chronic pain following a car accident three years ago. No history of substance abuse or dependence.The patient presents with chronic pain, insomnia, and irritability. Denies any history of drug abuse or withdrawal symptoms.Urine drug screen positive for opioids. No abnormalities in liver function tests or renal function tests.Opioid use, unspecified, with unspecified opioid-induced disorder. The patient exhibits chronic pain without clear evidence of abuse, dependence, intoxication, or withdrawal.The patient denies using opioids for recreational purposes. Appears to be using opioids for pain management. No signs of opioid intoxication or withdrawal observed during the examination.Initiated non-opioid pain management regimen. Referral to pain management specialist for further evaluation and treatment planning.Patient discharged in stable condition with a follow-up appointment scheduled with the pain management specialist in two weeks.45FemaleCaucasian"
    },
    "2562": {
        "explanation_text": "Cannabis abuse, uncomplicated.",
        "symptom_text": "The patient has a history of occasional Cannabis use during social gatherings in the past year.The patient reports increased tolerance to Cannabis, unsuccessful attempts to cut down use, and spending a great deal of time obtaining Cannabis.Urine drug screen positive for Cannabis metabolites.Cannabis abuse, uncomplicated. The patient exhibits increased tolerance, unsuccessful attempts to cut down, and spends a great deal of time obtaining Cannabis.The patient denies any symptoms of opioid, sedative, hypnotic, or anxiolytic use. No signs of opioid withdrawal, intoxication, or mood disorders are present.Initiated counseling sessions for substance abuse and referred the patient to a support group for further management.The patient responded well to counseling and showed motivation to address the Cannabis abuse. Discharged with a follow-up appointment in two weeks for monitoring progress.28MaleCaucasian"
    },
    "2563": {
        "explanation_text": "Cannabis dependence, uncomplicated.",
        "symptom_text": "The patient has a history of chronic cannabis use for the past 5 years, with increasing tolerance and withdrawal symptoms upon cessation.The patient presents with irritability, insomnia, decreased appetite, and cravings for cannabis.Urine drug screen positive for cannabinoids.Cannabis dependence, uncomplicated. Verbatim_EHR_quote_justifying_the_code: 'The patient meets the criteria for Cannabis dependence as per DSM-5, with evidence of tolerance, withdrawal symptoms, and continued use despite negative consequences.'The patient acknowledges the inability to cut down cannabis use and expresses a strong desire to quit.Initiated motivational interviewing sessions and referred the patient to a substance abuse counselor for cognitive-behavioral therapy.The patient was discharged with a follow-up appointment in two weeks to monitor progress and adjust the treatment plan if needed.32MaleCaucasian"
    },
    "2564": {
        "explanation_text": "Cannabis dependence, in remission.",
        "symptom_text": "The patient has a history of chronic cannabis use disorder with significant impairment in social and occupational functioning.Currently, the patient denies any cravings, withdrawal symptoms, or mood disturbances related to cannabis use.Urine drug screen was positive for cannabinoids and negative for other substances of abuse.Cannabis dependence, in remission (F12.21) - The patient presents with a history of cannabis dependence and is currently in remission without any active symptoms or impairment.The patient reports successfully abstaining from cannabis use for the past six months and shows no signs of current substance use disorder. Continuation of therapy and close monitoring are recommended.The patient is engaged in regular psychotherapy sessions focusing on relapse prevention and coping strategies. No pharmacological treatment is deemed necessary at this time.The patient is stable, in remission from cannabis dependence, and will continue outpatient therapy to maintain abstinence and prevent relapse.32MaleCaucasian"
    },
    "2565": {
        "explanation_text": "Cannabis use, unspecified, uncomplicated.",
        "symptom_text": "The patient has a history of occasional cannabis use for recreational purposes but denies any significant adverse effects or functional impairment related to its use.The patient reports mild relaxation and euphoria after cannabis use but denies any craving, tolerance, withdrawal symptoms, or negative consequences associated with its use.Urine drug screen positive for cannabinoids confirming recent cannabis use.Cannabis use, unspecified, uncomplicated. Verbatim EHR quote justifying the code: 'The patient's history and symptoms are consistent with occasional cannabis use without evidence of intoxication, withdrawal, or other substance-related issues.'The patient appears well-oriented, with stable vital signs and a normal neurological exam. No signs of acute intoxication or withdrawal are noted during the examination.Educated the patient on the potential risks of cannabis use and offered counseling for harm reduction strategies. Referral to a substance abuse support group was provided.28MaleCaucasian"
    },
    "2566": {
        "explanation_text": "Cannabis use, unspecified with psychotic disorder, unspecified.",
        "symptom_text": "The patient has a history of chronic cannabis use as reported by family members.The patient presents with auditory hallucinations, paranoid delusions, and disorganized speech.MRI and CT scans of the brain show no structural abnormalities.Cannabis use, unspecified with psychotic disorder, unspecified.The patient's symptoms of auditory hallucinations, paranoid delusions, and disorganized speech are consistent with a psychotic disorder, which developed in the context of chronic cannabis use. No evidence of opioid use or other substance-related disorders is present.The patient is started on antipsychotic medication for the management of psychotic symptoms. Referral to a substance abuse counselor is made to address the cannabis use.Patient responded well to treatment, with a reduction in hallucinations and delusions. Discharged with a follow-up appointment with the psychiatrist and substance abuse counselor.32MaleCaucasian"
    },
    "2567": {
        "explanation_text": "Cannabis use, unspecified with other cannabis-induced disorder.",
        "symptom_text": "The patient has a history of occasional cannabis use as self-reported during previous visits.The patient presents with increased anxiety, paranoia, and auditory hallucinations.Urine drug screen positive for cannabinoids.Cannabis use, unspecified with other cannabis-induced disorder (F12.988) - The patient presents with symptoms of increased anxiety, paranoia, and auditory hallucinations, along with a positive urine drug screen for cannabinoids, indicative of cannabis-induced psychotic disorder.The patient reports using cannabis to cope with stress and has experienced worsening paranoia and auditory hallucinations over the past month. No evidence of opioid, sedative, hypnotic, anxiolytic, or cocaine use.Initiated cognitive-behavioral therapy for substance use disorders and referred the patient to a psychiatrist for further evaluation and management of psychotic symptoms.The patient responded well to therapy and psychiatric management, with reduced symptoms of paranoia and hallucinations. Discharged with a follow-up appointment in two weeks for treatment monitoring.27MaleCaucasian"
    },
    "2568": {
        "explanation_text": "Sedative, hypnotic or anxiolytic abuse, uncomplicated.",
        "symptom_text": "The patient has a history of sedative, hypnotic, or anxiolytic use for coping with anxiety and stress.The patient reports increased tolerance to the sedative medication, frequent use to relieve tension, and occasional memory lapses.Laboratory tests show no abnormalities related to other substance abuse.Sedative, hypnotic or anxiolytic abuse, uncomplicated. Verbatim_EHR_quote_justifying_the_code: The patient presents with a clear history of sedative, hypnotic, or anxiolytic use without any associated complications.The physician notes the patient's self-reported misuse of sedatives for non-medical purposes, leading to the current diagnosis of Sedative, hypnotic or anxiolytic abuse, uncomplicated.The patient is started on a tapering schedule of the sedative medication under close monitoring to manage withdrawal symptoms and prevent further abuse.38FemaleCaucasian"
    },
    "2569": {
        "explanation_text": "Sedative, hypnotic or anxiolytic dependence, uncomplicated.",
        "symptom_text": "The patient has a history of chronic insomnia and anxiety for which they have been prescribed benzodiazepines intermittently over the past two years.The patient reports increasing tolerance to their prescribed benzodiazepines, withdrawal symptoms when not taking the medication, and continued use despite experiencing negative effects on their daily functioning.Urine toxicology screen positive for benzodiazepines.Sedative, hypnotic or anxiolytic dependence, uncomplicated. Verbatim_EHR_quote_justifying_the_code: 'The patient presents with increasing tolerance to benzodiazepines, withdrawal symptoms, and continued use despite negative consequences.'The patient appears anxious and demonstrates tremors during the physical examination. They acknowledge the inability to reduce or stop benzodiazepine use despite recognizing its adverse effects.Initiated a tapering schedule for benzodiazepines, referral to a substance abuse counselor for therapy, and follow-up in two weeks for monitoring.The patient responded well to the tapering schedule, with a reduction in withdrawal symptoms. Discharged with a plan for ongoing therapy and monitoring for benzodiazepine dependence.42FemaleCaucasian"
    },
    "2570": {
        "explanation_text": "Sedative, hypnotic or anxiolytic dependence with withdrawal delirium.",
        "symptom_text": "The patient has a history of chronic use of sedative medications for anxiety management.The patient presents with severe anxiety, tremors, hallucinations, and confusion upon abrupt discontinuation of sedative medications.Laboratory tests show no abnormalities other than those consistent with withdrawal from sedative medications.Sedative, hypnotic or anxiolytic dependence with withdrawal delirium (ICD-10-CM code F13231): The patient presents with severe anxiety, tremors, hallucinations, and confusion upon abrupt discontinuation of sedative medications.The patient's symptoms are consistent with withdrawal delirium following the abrupt cessation of sedative medications. No evidence of other substance use or withdrawal is noted.The patient was started on a tapering schedule of sedative medications to manage withdrawal symptoms. Close monitoring for potential complications of withdrawal delirium is ongoing.The patient responded well to the tapering schedule of sedative medications and showed improvement in symptoms. Discharged with a follow-up plan for monitoring and management of anxiety without the use of sedatives.45FemaleCaucasian"
    },
    "2571": {
        "explanation_text": "Cocaine abuse, uncomplicated.",
        "symptom_text": "The patient has a history of occasional cocaine use at social events over the past year.The patient presents with increased heart rate, dilated pupils, and restlessness.Urine toxicology screen positive for cocaine metabolites.Cocaine abuse, uncomplicated. Verbatim from ICD-10-CM: 'This code is for use when the focus of clinical attention is the maladaptive pattern of cocaine use leading to clinically significant impairment or distress.'Patient denies any other substance abuse. No signs of withdrawal or intoxication from other substances observed.Patient referred to a substance abuse counselor for therapy sessions. Encouraged to join a support group for individuals struggling with substance abuse.28MaleCaucasian"
    },
    "2572": {
        "explanation_text": "Cocaine abuse with intoxication, unspecified.",
        "symptom_text": "The patient has a history of occasional Cocaine use at parties and social gatherings.The patient presents with tachycardia, diaphoresis, dilated pupils, and psychomotor agitation.Urinalysis shows the presence of Cocaine metabolites.Acute Cocaine intoxication without any associated complications.The patient's symptoms and urine test results are consistent with acute Cocaine intoxication. No evidence of chronic abuse or withdrawal symptoms observed.The patient was closely monitored, provided supportive care, and encouraged to stay hydrated. Benzodiazepines were avoided due to the absence of significant central nervous system depression.28MaleCaucasian"
    },
    "2573": {
        "explanation_text": "Cocaine abuse with cocaine-induced mood disorder.",
        "symptom_text": "The patient has a history of cocaine abuse and is currently experiencing symptoms of mood disorder induced by cocaine use.The patient presents with increased irritability, depressed mood, and anxiety following cocaine use.Toxicology screening is positive for cocaine metabolites but negative for other substances.Cocaine abuse with cocaine-induced mood disorder (ICD-10-CM code F1414): The abuse of cocaine leading to a mood disorder characterized by a depressed mood, irritability, and anxiety.The patient reports a pattern of cocaine abuse and acknowledges the development of mood disturbances after cocaine use. Physical examination reveals no focal neurological deficits.The patient is started on supportive therapy and scheduled for counseling sessions to address substance abuse and mood disorder.The patient responded well to treatment and is being discharged with a follow-up plan for continued therapy and monitoring of substance abuse and mood symptoms.32MaleCaucasian"
    },
    "2574": {
        "explanation_text": "Cocaine abuse with other cocaine-induced disorder.",
        "symptom_text": "The patient has a history of chronic cocaine abuse with recurrent episodes of cocaine-induced disorders.The patient presents with paranoia, auditory hallucinations, and severe anxiety following cocaine use.Urinalysis shows the presence of cocaine metabolites consistent with recent cocaine use.Cocaine abuse with other cocaine-induced disorders (ICD-10-CM code F14188): The patient presents with paranoia, auditory hallucinations, and severe anxiety following cocaine use. Urinalysis confirms the presence of cocaine metabolites.The patient reports a history of escalating cocaine use over the past year, resulting in worsening psychiatric symptoms. There is no evidence of sedative, hypnotic, or anxiolytic use. The patient denies the use of other stimulants.The patient is referred to the addiction psychiatry service for substance abuse counseling and initiation of pharmacological therapy. Close monitoring for withdrawal symptoms and psychiatric complications is recommended.The patient responded well to treatment and is stable for discharge. Close outpatient follow-up is advised to monitor progress and prevent relapse.32MaleCaucasian"
    },
    "2575": {
        "explanation_text": "Cocaine dependence, uncomplicated.",
        "symptom_text": "The patient has a history of chronic cocaine use and has been struggling with addiction for the past two years.The patient presents with irritability, fatigue, increased appetite, and a strong craving for cocaine. No symptoms of abuse or intoxication are noted.Urinalysis confirms the presence of cocaine metabolites in the patient's system.Cocaine dependence, uncomplicated. Verbatim_EHR_quote_justifying_the_code: 'The patient meets the criteria for Cocaine dependence, including tolerance, withdrawal symptoms, and unsuccessful efforts to cut down use.'Patient appears anxious during the examination. Denies any recent cocaine use but acknowledges a strong desire to continue using. No signs of acute intoxication observed.The patient will be enrolled in a substance abuse treatment program focusing on behavioral therapy and counseling. Referral made to a support group for ongoing care.32MaleCaucasian"
    },
    "2576": {
        "explanation_text": "Cocaine use, unspecified, uncomplicated.",
        "symptom_text": "The patient has a history of occasional cocaine use but has not sought treatment for substance abuse in the past.The patient reports occasional cocaine use without any significant adverse effects.Urine drug screen positive for cocaine metabolites.Cocaine use, unspecified, uncomplicated. Verbatim from ICD-10-CM: 'This code is for use when the listed substance is unspecified. The complications include those related to the use of the substance.'Patient denies any withdrawal symptoms or cravings. No signs of intoxication or mood disorders observed.Patient education on the risks of cocaine use. Referral to a substance abuse counselor for further evaluation and support.The patient is stable and discharged with recommendations to follow up with the counselor for ongoing support.32MaleCaucasian"
    },
    "2577": {
        "explanation_text": "Other stimulant dependence, uncomplicated.",
        "symptom_text": "The patient has a history of chronic stimulant use, primarily involving substances other than cocaine or nicotine.The patient reports a strong desire to use stimulants, difficulty controlling use, and continued use despite negative consequences. There are no symptoms of intoxication, withdrawal, or mood disorders related to cocaine or nicotine.Urine drug screen is positive for stimulants other than cocaine or nicotine.Other stimulant dependence, uncomplicated. The patient exhibits a strong desire to use stimulants, difficulty controlling use, and continued use despite negative consequences, without symptoms of intoxication, withdrawal, or mood disorders related to cocaine or nicotine.The patient presents with a clear pattern of stimulant dependence, focusing on substances other than cocaine or nicotine. No evidence of acute intoxication, withdrawal, or mood disturbances related to cocaine or nicotine use.The patient is referred to a substance abuse treatment program for counseling and therapy to address stimulant dependence.The patient is stable and discharged with a follow-up appointment scheduled at the substance abuse treatment center.32MaleCaucasian"
    },
    "2578": {
        "explanation_text": "Other stimulant dependence, in remission.",
        "symptom_text": "The patient has a history of stimulant use disorder involving substances other than cocaine, with a documented period of remission.The patient is currently asymptomatic and denies any symptoms related to stimulant use or withdrawal.Laboratory tests show no evidence of recent stimulant use or physiological effects of stimulant withdrawal.Other stimulant dependence, in remissionPatient appears stable with no acute concerns. Denies any cravings or desire to use stimulants. Recommending continued monitoring for relapse prevention.Focused on counseling for relapse prevention strategies and ongoing support for maintaining remission.Patient discharged in stable condition with a follow-up appointment scheduled for monitoring progress in maintaining remission.38MaleCaucasian"
    },
    "2579": {
        "explanation_text": "Other stimulant use, unspecified, uncomplicated.",
        "symptom_text": "The patient has a history of occasional stimulant use but denies any prior diagnosis of abuse, dependence, or withdrawal symptoms related to stimulants.The patient presents with mild insomnia and increased alertness, which are attributed to the stimulant use. There are no signs of withdrawal, intoxication, or severe dependence.Urine drug screen is positive for stimulants, confirming recent stimulant use. Other lab results, including liver and kidney function tests, are within normal limits.Other stimulant use, unspecified, uncomplicated. Verbatim EHR quote justifying the code: 'Patient presents with a history of occasional stimulant use without evidence of abuse, dependence, withdrawal, or intoxication.'The physician notes that the patient's symptoms are consistent with uncomplicated stimulant use, with no indications of abuse, dependence, or withdrawal.The patient was advised on the risks of stimulant use and offered counseling services for substance use. No pharmacological treatment was deemed necessary.The patient's symptoms improved with counseling, and there were no complications observed during the hospital stay. The patient was discharged with recommendations for follow-up counseling sessions.32MaleCaucasian"
    },
    "2580": {
        "explanation_text": "Hallucinogen use, unspecified, uncomplicated.",
        "symptom_text": "The patient has no significant medical history of psychiatric disorders or substance use disorders.The patient presents with visual hallucinations, paranoia, and disorganized behavior.Toxicology screening is positive for hallucinogens.Hallucinogen use, unspecified, uncomplicated. The patient's symptoms and positive toxicology screening support the diagnosis of hallucinogen use without specifying a particular substance.The patient denies any specific substance use but admits to recent experimentation with hallucinogenic drugs. No evidence of withdrawal symptoms or tolerance noted.The patient was provided with supportive care and psychoeducation on substance use disorders. Referral to outpatient counseling services for substance abuse was recommended.The patient responded well to treatment, with a resolution of hallucinations and paranoia. Discharged in stable condition with a follow-up appointment scheduled.27MaleCaucasian"
    },
    "2581": {
        "explanation_text": "Nicotine dependence, unspecified, uncomplicated.",
        "symptom_text": "The patient has a history of chronic tobacco use for several years.The patient reports a strong craving for tobacco, increased tolerance to nicotine, and unsuccessful efforts to cut down or control tobacco use.Nicotine levels in the patient's blood are elevated, confirming active tobacco use.Nicotine dependence, unspecified, uncomplicated. The patient exhibits a strong craving for tobacco, increased tolerance, and unsuccessful efforts to cut down tobacco use.The patient shows signs of nicotine dependence with typical withdrawal symptoms upon attempting to quit smoking. No symptoms of other substance abuse or dependence are present.The patient was advised on smoking cessation programs, nicotine replacement therapy, and behavioral counseling.The patient was discharged with a follow-up appointment scheduled to monitor progress in smoking cessation efforts.45MaleCaucasian"
    },
    "2582": {
        "explanation_text": "Nicotine dependence, cigarettes, in remission.",
        "symptom_text": "The patient has a history of chronic smoking and nicotine dependence, with previous unsuccessful attempts to quit smoking.The patient reports a past significant smoking habit, craving for cigarettes, but currently denies active smoking and withdrawal symptoms.Nicotine levels in the urine test are negative, indicating no recent exposure to nicotine.Nicotine dependence, cigarettes, in remission. The patient has successfully abstained from smoking, with no current symptoms of withdrawal or active smoking behavior.Patient shows good insight into the health risks associated with smoking and is committed to maintaining smoking cessation. Encouraged to continue with smoking cessation programs and follow-up visits.Continuation of behavioral therapy for smoking cessation, support groups, and nicotine replacement therapy if needed.The patient is stable, educated on the importance of maintaining smoking cessation, and scheduled for follow-up visits to monitor progress.45MaleCaucasian"
    },
    "2583": {
        "explanation_text": "Nicotine dependence, cigarettes, with withdrawal.",
        "symptom_text": "The patient has a 10-year history of smoking one pack of cigarettes daily.The patient presents with cravings, irritability, anxiety, and difficulty concentrating.Nicotine metabolites were detected in the urine test.Nicotine dependence, cigarettes, with withdrawal (ICD-10-CM code F17213): The patient has a 10-year history of smoking one pack of cigarettes daily. The patient presents with cravings, irritability, anxiety, and difficulty concentrating. Nicotine metabolites were detected in the urine test.Patient exhibits classic symptoms of nicotine withdrawal including cravings, irritability, anxiety, and difficulty concentrating. Recommended nicotine replacement therapy and behavioral counseling.1. Nicotine replacement therapy with patches. 2. Referral to a behavioral counselor for smoking cessation program.45MaleCaucasian"
    },
    "2584": {
        "explanation_text": "Nicotine dependence, cigarettes, with other nicotine-induced disorders.",
        "symptom_text": "The patient has a history of chronic cigarette smoking for the past 10 years, with an average consumption of one pack per day. No history of other substance abuse or dependence.The patient presents with a persistent cough, shortness of breath, and chest tightness. Additionally, the patient experiences anxiety, restlessness, and difficulty concentrating.Pulmonary function tests indicate mild obstructive lung disease. Urine toxicology screen is positive for nicotine metabolites.Nicotine dependence, cigarettes, with other nicotine-induced disorders. Verbatim EHR quote justifying the code: 'Patient presents with a history of chronic cigarette smoking, along with symptoms of nicotine dependence and evidence of nicotine-induced disorders.'Patient appears anxious during the examination. Lung auscultation reveals wheezing in the lower lung fields. The patient acknowledges the inability to quit smoking despite multiple attempts.Initiated nicotine replacement therapy and scheduled counseling sessions for smoking cessation. Prescribed albuterol inhaler for symptom management.Patient responded well to treatment and counseling. Advised to continue nicotine replacement therapy and follow up with the pulmonologist for further management of lung disease.45MaleCaucasian"
    },
    "2585": {
        "explanation_text": "Nicotine dependence, cigarettes, with unspecified nicotine-induced disorders.",
        "symptom_text": "The patient has a significant history of smoking cigarettes for the past 15 years, with unsuccessful attempts to quit in the past. No history of stimulant or hallucinogen use.The patient presents with a persistent cough, shortness of breath, and wheezing. Denies any hallucinations, delusions, or mood disturbances.Pulmonary function tests show mild obstructive lung disease. Urine toxicology screen is positive for nicotine metabolites.Nicotine dependence, cigarettes, with unspecified nicotine-induced disorders (F17219)The patient exhibits physical signs of chronic smoking, including nicotine-stained fingers and dental discoloration. Lung auscultation reveals wheezing. No signs of stimulant or hallucinogen use.Initiated nicotine replacement therapy and scheduled for smoking cessation counseling sessions. Albuterol inhaler prescribed for symptomatic relief.Patient responded well to treatment and education on smoking cessation. Scheduled for follow-up in two weeks for further evaluation of lung function.45MaleCaucasian"
    },
    "2586": {
        "explanation_text": "Nicotine dependence, other tobacco product, uncomplicated.",
        "symptom_text": "The patient has a history of smoking tobacco products regularly for the past 10 years.The patient reports a strong craving for tobacco, increased tolerance to nicotine, and continued tobacco use despite awareness of its harmful effects.Nicotine levels in the patient's blood are elevated, confirming active tobacco use.Nicotine dependence, other tobacco product, uncomplicated. The patient exhibits a strong craving for tobacco, increased tolerance, and continued use despite the knowledge of its adverse effects.The patient shows clear signs of dependence on tobacco products, with no evidence of withdrawal symptoms or other substance use disorders.The patient is advised to enroll in a smoking cessation program, offered nicotine replacement therapy, and scheduled for regular counseling sessions.The patient responded well to the treatment plan and is encouraged to continue with the smoking cessation program post-discharge.45MaleCaucasian"
    },
    "2587": {
        "explanation_text": "Other psychoactive substance abuse, uncomplicated.",
        "symptom_text": "The patient has a history of occasional recreational use of a specific psychoactive substance.The patient reports occasional substance use without significant withdrawal symptoms or complications.Toxicology screening is positive for the specific psychoactive substance, confirming recent use.Other psychoactive substance abuse, uncomplicated. Verbatim from ICD-10-CM: 'This code is for use when the psychoactive substance(s) being used cannot be classified to the more specific categories of other psychoactive substance-related disorders.'Patient denies any withdrawal symptoms or tolerance development. No indications of mood or psychotic disorders related to substance use observed.Patient education on the risks of substance abuse, counseling sessions arranged, and follow-up scheduled to monitor substance use.The patient was discharged in stable condition with a follow-up appointment scheduled for monitoring substance use and providing ongoing support.32MaleCaucasian"
    },
    "2588": {
        "explanation_text": "Other psychoactive substance abuse, in remission.",
        "symptom_text": "The patient has a history of psychoactive substance abuse but is currently in remission.The patient denies any current substance use and reports no withdrawal symptoms, mood disorders, or psychotic symptoms.Toxicology screening is negative for any psychoactive substances.Other psychoactive substance abuse, in remission (F19.11) - The patient has a history of psychoactive substance abuse but is currently in remission, as evidenced by the absence of current substance use, withdrawal symptoms, mood disorders, or psychotic symptoms.The patient shows good insight into their past substance abuse issues and is committed to maintaining sobriety. No signs of current substance use or related complications are noted.The patient is referred to a substance abuse counselor for ongoing support and attends regular therapy sessions to prevent relapse.The patient is stable with no acute concerns. Discharged with recommendations for continued therapy and support for substance abuse recovery.35MaleCaucasian"
    },
    "2589": {
        "explanation_text": "Other psychoactive substance abuse with psychoactive substance-induced mood disorder.",
        "symptom_text": "The patient has a history of substance abuse, including the use of psychoactive substances. No history of nicotine dependence or tobacco use.The patient presents with mood disturbances, including depressive symptoms, which are temporally related to the use of psychoactive substances. No symptoms of nicotine dependence, withdrawal, or other nicotine-induced disorders.Laboratory tests show no evidence of nicotine or tobacco use. Toxicology screening is positive for other psychoactive substances.Other psychoactive substance abuse with psychoactive substance-induced mood disorder. The patient's mood disturbances are directly linked to the use of psychoactive substances, supporting the diagnosis of F1914.The patient denies any history of tobacco use but admits to the abuse of other psychoactive substances. The onset of mood disturbances coincides with the use of these substances, indicating a substance-induced etiology.The patient is referred to a substance abuse treatment program for psychotherapy and pharmacotherapy targeting both substance abuse and mood disorder symptoms.The patient responded well to the treatment and is advised to continue therapy on an outpatient basis. Follow-up appointments are scheduled to monitor progress.32MaleCaucasian"
    },
    "2590": {
        "explanation_text": "Other psychoactive substance dependence, uncomplicated.",
        "symptom_text": "The patient has a history of chronic use of a psychoactive substance, leading to social and occupational impairment. No history of nicotine dependence or abuse.The patient reports cravings for the substance, unsuccessful efforts to cut down, and continued use despite awareness of the problems caused by it.Lab tests show no signs of nicotine use or withdrawal. Toxicology screening is positive for the specific psychoactive substance.Other psychoactive substance dependence, uncomplicated. Verbatim ICD-10-CM's verbatim_EHR_quote_justifying_the_code: 'The patient presents with a maladaptive pattern of substance use, leading to clinically significant impairment or distress.'Patient denies nicotine use but admits to regular use of another psychoactive substance. No withdrawal symptoms noted. Social work consultation scheduled for further support.Initiated psychotherapy sessions focusing on substance dependence. Referral made to a substance abuse counselor for outpatient follow-up.Patient discharged in stable condition with scheduled follow-up appointments for therapy and counseling sessions.38MaleCaucasian"
    },
    "2591": {
        "explanation_text": "Other psychoactive substance dependence, in remission.",
        "symptom_text": "The patient has a history of chronic psychoactive substance dependence, with multiple unsuccessful attempts at quitting. No history of substance abuse or mood disorders.Currently, the patient is stable with no withdrawal symptoms or cravings. Denies any substance use for the past six months.Urine drug screen is negative for all substances of abuse. Liver function tests are within normal limits.Other psychoactive substance dependence, in remission (F1921)Patient presents with a strong commitment to sobriety, actively engaging in therapy sessions, and showing significant improvement in personal and social functioning.Continuation of individual and group therapy for substance use disorder. Referral to a support group for ongoing sobriety maintenance.Patient discharged in stable condition with a follow-up appointment scheduled in one month.42MaleCaucasian"
    },
    "2592": {
        "explanation_text": "Other psychoactive substance use, unspecified with intoxication with delirium.",
        "symptom_text": "The patient has a history of sporadic substance use but denies any formal diagnosis of substance abuse or dependence.The patient presents with altered mental status, confusion, disorientation, and visual hallucinations.Laboratory tests show elevated liver enzymes consistent with toxic substance exposure. Urine toxicology is positive for psychoactive substances.Other psychoactive substance use, unspecified with intoxication with delirium (F19921)The patient's presentation is indicative of acute intoxication with a psychoactive substance leading to delirium. The symptoms and test results align with this diagnosis.The patient was closely monitored, provided with supportive care, and gradually improved with symptomatic treatment. Psychiatric consultation was obtained for further evaluation and follow-up.The patient's condition significantly improved with treatment, and he was discharged with recommendations for follow-up with the psychiatric team.32MaleCaucasian"
    },
    "2593": {
        "explanation_text": "Other psychoactive substance use, unspecified with psychoactive substance-induced mood disorder.",
        "symptom_text": "The patient has a history of substance use disorder with multiple failed attempts at rehabilitation programs.The patient presents with irritability, depressed mood, and anhedonia after using psychoactive substances.Urine toxicology screen is positive for the presence of psychoactive substances.Other psychoactive substance use, unspecified with psychoactive substance-induced mood disorder (F19.94)The patient reports a pattern of using various psychoactive substances to cope with stress and negative emotions, leading to a persistent mood disorder. The diagnostic criteria for F1994 are clearly met based on the patient's history of substance use, the presence of mood disorder symptoms, and the positive urine toxicology screen.The patient is started on a detoxification program, along with psychotherapy to address the underlying mood disorder. Referral to a substance abuse counselor is also made.The patient responded well to treatment and is advised to continue therapy on an outpatient basis. Follow-up appointments are scheduled to monitor progress.32MaleCaucasian"
    },
    "2594": {
        "explanation_text": "Other psychoactive substance use, unspecified with psychoactive substance-induced psychotic disorder, unspecified.",
        "symptom_text": "The patient has a history of occasional substance use but no prior documented substance abuse or dependence. There is no history of schizophrenia, schizoaffective disorders, or other psychotic disorders.The patient presents with auditory hallucinations, paranoid delusions, and disorganized speech. There are no symptoms of tobacco or nicotine dependence, mood disorders, or withdrawal.MRI and CT scans of the brain are unremarkable. Toxicology screening is positive for an unspecified psychoactive substance.Other psychoactive substance use, unspecified with psychoactive substance-induced psychotic disorder, unspecified. Verbatim EHR quote justifying the code: 'The patient exhibits symptoms of auditory hallucinations, paranoid delusions, and disorganized speech in the absence of any mood disorder or tobacco/nicotine-related symptoms.'The patient's psychosis appears to be directly related to the use of an unspecified psychoactive substance. No signs of withdrawal or mood disorder are evident.The patient is started on antipsychotic medication for the psychotic symptoms. Psychotherapy sessions are scheduled to address substance use.The patient's psychotic symptoms have improved significantly with medication. Discharge instructions include follow-up with both psychiatry and addiction medicine specialists.34MaleCaucasian"
    },
    "2595": {
        "explanation_text": "Catatonic schizophrenia.",
        "symptom_text": "The patient has a history of chronic schizophrenia with multiple hospital admissions for psychotic episodes.The patient presents with stupor, mutism, posturing, and echolalia. Exhibits waxy flexibility and negativism.MRI and EEG are within normal limits.Catatonic schizophrenia is characterized by a prominent catatonic behavior, including stupor, mutism, posturing, and echolalia. The patient also exhibits waxy flexibility and negativism.The patient's catatonic symptoms are consistent with a diagnosis of catatonic schizophrenia. No evidence of substance abuse or other schizophrenia subtypes is present.Initiated treatment with antipsychotic medication and scheduled for electroconvulsive therapy (ECT) to address catatonia.The patient showed improvement in catatonic symptoms with ECT and antipsychotic medication. Discharged with a follow-up plan for outpatient therapy and medication management.38MaleCaucasian"
    },
    "2596": {
        "explanation_text": "Schizotypal disorder.",
        "symptom_text": "The patient has a history of social withdrawal, odd beliefs, and paranoid thoughts.The patient presents with social anxiety, odd perceptual experiences, and suspiciousness.Psychological testing revealed high levels of social anxiety and odd thinking patterns consistent with Schizotypal disorder.Schizotypal disorder (F21) - The patient exhibits a pervasive pattern of social and interpersonal deficits, along with cognitive or perceptual distortions and eccentric behavior. Verbatim EHR quote justifying the code: 'The patient's symptoms align with the diagnostic criteria for Schizotypal disorder, including social anxiety, odd beliefs, and paranoid ideation.'The patient demonstrates peculiar behavior, has few close relationships, and experiences significant social anxiety. No evidence of mood disturbances or psychotic symptoms.The patient will receive cognitive-behavioral therapy to address social anxiety and improve social skills.The patient responded well to therapy, showing decreased social anxiety and improved social interactions. Follow-up appointments are scheduled for ongoing support.32MaleCaucasian"
    },
    "2597": {
        "explanation_text": "Delusional disorders.",
        "symptom_text": "The patient has no history of substance use disorders or mood disorders.The patient presents with non-bizarre delusions of persecution and reference. There are no hallucinations, mood symptoms, or substance withdrawal signs.MRI and EEG results are unremarkable, ruling out structural brain abnormalities or epileptic activity.Delusional disorder (F22): The essential feature is the presence of one or more non-bizarre delusions that persist for at least one month. The delusions involve situations that occur in real life, such as being followed, poisoned, infected, loved at a distance, or deceived by a spouse or lover. Hallucinations, if present, are not prominent and are related to the delusional theme.The patient exhibits fixed false beliefs of being persecuted and spied on, which are not in line with reality. No hallucinations or mood disturbances are noted. The patient denies any substance use.The patient is started on cognitive behavioral therapy to address the delusional beliefs. Antipsychotic medication (aripiprazole) is initiated at a low dose to manage the delusional symptoms.Upon discharge, the patient's delusions have shown some improvement with aripiprazole. Follow-up with outpatient therapy is recommended to monitor the progress of the delusional symptoms.42MaleCaucasian"
    },
    "2598": {
        "explanation_text": "Brief psychotic disorder.",
        "symptom_text": "The patient has no prior history of psychiatric disorders or substance use disorders.The patient, a 35-year-old male, presented with acute onset hallucinations, delusions, and disorganized speech over the last week. He has no history of similar episodes in the past.MRI and blood tests were unremarkable, ruling out any organic causes for the psychotic symptoms.Brief psychotic disorder (F23): The essential features include a sudden onset of at least one psychotic symptom (hallucinations, delusions, disorganized speech) lasting between 1 day to 1 month, with eventual full return to premorbid functioning. The symptoms are not better explained by another mental disorder or substance use.The patient's symptoms meet the diagnostic criteria for Brief psychotic disorder. There is no evidence of mood symptoms or significant functional impairment. The patient denies any substance use or history of mood disorders.The patient was started on low-dose antipsychotic medication and scheduled for regular follow-up appointments with a psychiatrist.At discharge, the patient's psychotic symptoms had significantly improved with medication. He was advised to continue the antipsychotic treatment and attend therapy sessions for further support.35MaleNot specified"
    },
    "2599": {
        "explanation_text": "Schizoaffective disorder, bipolar type.",
        "symptom_text": "The patient has a history of recurrent mood episodes characterized by manic and depressive symptoms, along with intermittent psychotic features. No history of substance abuse or other significant medical conditions.The patient presents with periods of elevated mood, increased energy, decreased need for sleep, racing thoughts, grandiosity, and impulsivity during manic episodes. Depressive symptoms include low mood, loss of interest, feelings of worthlessness, and suicidal ideation. Psychotic features consist of auditory hallucinations and paranoid delusions.Laboratory tests, including complete blood count, comprehensive metabolic panel, thyroid function tests, and urine drug screen, were within normal limits. Brain imaging studies showed no significant abnormalities.Schizoaffective disorder, bipolar type. The patient exhibits a combination of mood symptoms (manic and depressive) and psychotic features, meeting the diagnostic criteria for Schizoaffective disorder, bipolar type.The patient's presentation is consistent with Schizoaffective disorder, bipolar type. The treatment plan includes mood stabilizers and atypical antipsychotic medications to manage mood symptoms and psychotic features effectively.The patient is started on lithium for mood stabilization and risperidone for managing psychotic symptoms. Psychoeducation and cognitive-behavioral therapy sessions are planned to enhance coping strategies and improve overall functioning.The patient responded well to the pharmacological and therapeutic interventions during hospitalization. Discharged home with close outpatient follow-up for medication management and therapy sessions.34FemaleCaucasian"
    }
}